Indicators of Data Quality at the Cancer Registry Zurich and Zug in Switzerland

被引:22
作者
Wanner, Miriam [1 ,2 ]
Matthes, Katarina L. [1 ,2 ]
Korol, Dinutri [1 ]
Dehler, Silvia [1 ,2 ]
Rohrmann, Sabine [1 ,2 ]
机构
[1] Univ Hosp Zurich, Inst Pathol & Mol Pathol, Canc Registry Zurich & Zug, Zurich, Switzerland
[2] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland
关键词
CUTANEOUS MELANOMA; SKIN MELANOMA; TIME TRENDS; COMPLETENESS; TIMELINESS; COMPARABILITY; VALIDITY; MORTALITY; EUROPE;
D O I
10.1155/2018/7656197
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Data quality is an important issue in cancer registration. This paper provides a comprehensive overview of the four main data quality indicators (comparability, validity, timeliness, and completeness) for the Cancer Registry Zurich and Zug (Switzerland). We extracted all malignant cancer cases (excluding non-melanoma skin cancer) diagnosed between 1980 and 2014 in the canton of Zurich. Methods included the proportion of morphologically verified cases (MV%), the proportion of DCN and DCO cases (2009-2014), cases with primary site uncertain (PSU%), the stability of incidence rates over time, age-specific incidence rates for childhood cancer, and mortality: incidence (MI) ratios. The DCO rate decreased from 6.4% in 1997 to 0.8% in 2014 and was <5% since 2000. MV% was 95.5% in 2014. PSU% was <3% over the whole period. The incidence rate of all tumours increased over time with site-specific fluctuations. The overall M: I ratio decreased from 0.58 in 1980 to 0.37 in 2014. Overall, data quality of the Cancer Registry Zurich and Zug was acceptable according to the methods presented in this review. Most indicators improved over time with low DCO rates, high MV%, low PSU%, relatively low M: I ratios and age-specific incidence of childhood cancer within reference ranges.
引用
收藏
页数:11
相关论文
共 27 条
  • [1] Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timeliness
    Bray, Freddie
    Parkin, D. Max
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (05) : 747 - 755
  • [2] Bullard J., BRIT J CANC, V82, P1111
  • [3] Cendales R, 2012, BIOMEDICA, V32, P536, DOI [10.7705/biomedica.v32i4.756, 10.1590/S0120-41572012000400009]
  • [4] Dehler S, 2014, TUMORI, V100, P399, DOI 10.1700/1636.17894
  • [5] Data quality at the Bulgarian National Cancer Registry: An overview of comparability, completeness, validity and timeliness
    Dimitrova, Nadya
    Parkin, Donald Maxwell
    [J]. CANCER EPIDEMIOLOGY, 2015, 39 (03) : 405 - 413
  • [6] The completeness and timeliness of cancer registration and the implications for measuring cancer burden
    Donnelly, Conan
    Cairnduff, Victoria
    Chen, Jingwen Jessica
    Kearney, Therese
    Fitzpatrick, Deirdre
    Fox, Colin
    Gavin, Anna
    [J]. CANCER EPIDEMIOLOGY, 2017, 49 : 101 - 107
  • [7] Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
    Ferlay, J.
    Steliarova-Foucher, E.
    Lortet-Tieulent, J.
    Rosso, S.
    Coebergh, J. W. W.
    Comber, H.
    Forman, D.
    Bray, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1374 - 1403
  • [8] Data quality at the Singapore Cancer Registry: An overview of comparability, completeness, validity and timeliness
    Fung, Janice Wing Mei
    Lim, Sandra Bee Lay
    Zheng, Huili
    Ho, William Ying Tat
    Lee, Bee Guat
    Chow, Khuan Yew
    Lee, Hin Peng
    [J]. CANCER EPIDEMIOLOGY, 2016, 43 : 76 - 86
  • [9] Estimation of completeness of case ascertainment of Austrian cancer incidence data using the flow method
    Hackl, Monika
    Waldhoer, Thomas
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2013, 23 (05) : 889 - 893
  • [10] [Jensen OM. IARC publication IARC publication], 1991, CANC REGISTRATION PR